These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 626193)

  • 1. Controlling thrombophlebitis from amphotericin B.
    Arbuthnot R; Dullea A; Rippel S
    Am J Hosp Pharm; 1978 Feb; 35(2):129. PubMed ID: 626193
    [No Abstract]   [Full Text] [Related]  

  • 2. Taking the terror out of amphotericin B.
    Mahon SM
    Am J Nurs; 1988 Jul; 88(7):960-4. PubMed ID: 3381848
    [No Abstract]   [Full Text] [Related]  

  • 3. Amphotericin B: effective management of adverse reactions.
    Anderson M; Faulkner N
    Cancer Nurs; 1982 Dec; 5(6):461-3. PubMed ID: 6924601
    [No Abstract]   [Full Text] [Related]  

  • 4. Compatibility of amphotericin B with drugs used to reduce adverse reactions.
    Gotz VP; Mar DD; Roche JJ
    Am J Hosp Pharm; 1981 Mar; 38(3):378-9. PubMed ID: 7223754
    [No Abstract]   [Full Text] [Related]  

  • 5. Pretreatment regimens for adverse events related to infusion of amphotericin B.
    Goodwin SD; Cleary JD; Walawander CA; Taylor JW; Grasela TH
    Clin Infect Dis; 1995 Apr; 20(4):755-61. PubMed ID: 7795069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thrombosis following amphotericin B administration.
    Warr OS; Sutliff WD
    Antimicrob Agents Chemother (Bethesda); 1967; 7():739-41. PubMed ID: 5596215
    [No Abstract]   [Full Text] [Related]  

  • 7. Amphotericin B--specifics of administration.
    Goodman JS; Koenig MG
    Mod Treat; 1970 May; 7(3):581-95. PubMed ID: 4920806
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and serologic features of 47 patients with paracoccidioidomycosis treated by amphotericin B.
    de Campos EP; Sartori JC; Hetch ML; de Franco MF
    Rev Inst Med Trop Sao Paulo; 1984; 26(4):212-7. PubMed ID: 6522952
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs for the treatment of systemic fungal infections.
    Med Lett Drugs Ther; 1978 Jul; 20(15):66-8. PubMed ID: 661747
    [No Abstract]   [Full Text] [Related]  

  • 10. Amphotericin B: Ten common questions.
    Comer JB
    Am J Nurs; 1981 Jun; 81(6):1166-7. PubMed ID: 6909008
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical application of research utilization: amphotericin B.
    Reedy AM; Shivnan JC; Hanson JL; Haisfield ME; Gregory RE
    Oncol Nurs Forum; 1994 May; 21(4):715-9. PubMed ID: 8047470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective systemic antifungal agents.
    Lefrock JL; Smith BR
    Am Fam Physician; 1984 Dec; 30(6):162-7. PubMed ID: 6095631
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intravenous amphotericin B at home, why not?].
    Fernández-Miera M; Fariñas Alvarez Mdel C; Hazas Feo MJ; Sanroma Mendizábal P
    Med Clin (Barc); 1994 Mar; 102(11):434-5. PubMed ID: 8183004
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe thrombophlebitis with naftidrofuryl oxalate.
    Gann M
    Br Med J; 1977 Jun; 1(6076):1598. PubMed ID: 871682
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperkalemia associated with rapid infusion of conventional and lipid complex formulations of amphotericin B.
    Barcia JP
    Pharmacotherapy; 1998; 18(4):874-6. PubMed ID: 9692667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient asystole associated with amphotericin B infusion.
    DeMonaco HJ; McGovern B
    Drug Intell Clin Pharm; 1983; 17(7-8):547-8. PubMed ID: 6347598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of liposomal amphotericin B in a case of amphotericin B-induced nephrogenic diabetes insipidus.
    Späth-Schwalbe E; Koschuth A; Dietzmann A; Schanz J; Possinger K
    Clin Infect Dis; 1999 Mar; 28(3):680-1. PubMed ID: 10194097
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pulmonary mucormycosis: benefit of aerosol amphotericin B?].
    Furco A; Mouchet B; Carbonnelle M; Vallerand H
    Rev Mal Respir; 2001 Jun; 18(3):309-13. PubMed ID: 11468594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex.
    Ozaras R; Yemisen M; Mete B; Mert A; Ozturk R; Tabak F
    Mycoses; 2007 May; 50(3):242. PubMed ID: 17472626
    [No Abstract]   [Full Text] [Related]  

  • 20. Amphotericin B therapy in kala-azar.
    Giri OP
    J Indian Med Assoc; 1993 Apr; 91(4):91-3. PubMed ID: 8409490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.